Session Details
JSNM Symposium 4:Essential Examinations in Anti–Amyloid-β Antibody Treatment Strategies
Sat. Nov 15, 2025 9:50 AM - 11:50 AM JST
Sat. Nov 15, 2025 12:50 AM - 2:50 AM UTC
Sat. Nov 15, 2025 12:50 AM - 2:50 AM UTC
Room 5（B1F, Exhibition Hall 1 B, Kyoto International Exhibition Hall 'Miyako Messe'）
Chair: Kazunari Ishii (Department of Radiology, Kobe University Graduate School of Medicine), Ishii Kenji (Team for Neuroimaging Research, Tokyo Metropolitan Institute for Geriatrics and Gerontology)
On-Demand Streaming available
[MSY4-1]Drug Treatment Strategies: The Role of Brain MRI
Aya M. Tokumaru (Department of Diagnostic Radiology, Tokyo Metropolitan Institute for Geriatrics and Gerontology)
[MSY4-2]Brain perfusion SPECT and FDG PET
Kengo Ito (National Center for Geriatrics and Gerontology)
[MSY4-3]Brain Amyloid PET
Hiroshi Matsuda1,2 (1.Drug Discovery and Cyclotron Research Center, Southern Tohoku Research Institute for Neuroscience、2.Clinical Imaging Center for Healthcare, Nippon Medical School)
[MSY4-4]Tau PET perspectives on optimizing amyloid-targeted therapy and remaining challenges
Hitoshi Shimada1,2 (1.Department of Functional Neurology & Neurosurgery, Center for Integrated Human Brain Science, Brain Research Institute, Niigata University、2.Advanced Neuroimaging Center, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology)
[MSY4-5]Fluid Biomarkers for Dementia in the Era of Anti-Amyloid beta Antibody Drugs
Takahiko Tokuda (Department of Neuroetiology and Diagnostic Science, Healthy Longevity Medicine, Osaka Metropolitan University Graduate School of Medicine)